KKR & Co. Inc., 10% Owner at BridgeBio Pharma, Inc. (BBIO), bought 36,900,661 shares at $17.00 ($45.0M) on 2019-07-01, disclosed to the SEC on 2019-07-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 34,253,561 | $0 | 0.0% |
| 2 | $17.00 | 2,647,100 | $45.0M | 100.0% |
| Total | $1.22 avg | 36,900,661 | $45.0M | 100% |
| Filing → |
| BBIO | SELL | 2024-09-17 | $149.3M | — | Filing → |
| LAUR | SELL | 2022-11-22 | $618.1M | — | Filing → |
| APP | SELL | 2021-12-09 | $677.1M | — | Filing → |